Angela A. Armstrong

Array ( [id] => 17783581 [patent_doc_number] => 11406686 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-09 [patent_title] => Methods for the treatment of tissue lesions with CCR2 agonists [patent_app_type] => utility [patent_app_number] => 16/098689 [patent_app_country] => US [patent_app_date] => 2017-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 45 [patent_no_of_words] => 11894 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17741434 [patent_doc_number] => 11389479 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-07-19 [patent_title] => T cell differentiation and function regulation by decreasing let7 expression [patent_app_type] => utility [patent_app_number] => 16/097467 [patent_app_country] => US [patent_app_date] => 2017-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 53 [patent_no_of_words] => 23223 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14342165 [patent_doc_number] => 20190153055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-23 [patent_title] => FUSION PROTEIN COMPRISING CCL3 VARIANT AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/097572 [patent_app_country] => US [patent_app_date] => 2017-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8235 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11993962 [patent_doc_number] => 20170298115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-19 [patent_title] => 'HUMANIZED ANTI-PACAP ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/487642 [patent_app_country] => US [patent_app_date] => 2017-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 59 [patent_figures_cnt] => 59 [patent_no_of_words] => 111411 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15487642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14182749 [patent_doc_number] => 20190111079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-04-18 [patent_title] => MULTI-SPECIFIC ANTIGEN-BINDING CONSTRUCTS TARGETING IMMUNOTHERAPEUTICS [patent_app_type] => utility [patent_app_number] => 16/088760 [patent_app_country] => US [patent_app_date] => 2017-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31380 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -55 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16088760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12009705 [patent_doc_number] => 09803011 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-31 [patent_title] => 'Anti-hepcidin antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 15/485141 [patent_app_country] => US [patent_app_date] => 2017-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 32 [patent_no_of_words] => 43720 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15485141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13856381 [patent_doc_number] => 10189901 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-01-29 [patent_title] => Methods for improving cardiac function by administering an antibody that activates APLNR [patent_app_type] => utility [patent_app_number] => 15/480199 [patent_app_country] => US [patent_app_date] => 2017-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 31556 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15480199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14156533 [patent_doc_number] => 20190105369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-04-11 [patent_title] => CD31SHED AGONISTS FOR USE IN THE PREVENTION AND/OR TREATMENT OF REPERFUSION INJURY [patent_app_type] => utility [patent_app_number] => 16/087223 [patent_app_country] => US [patent_app_date] => 2017-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12952 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16087223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11716112 [patent_doc_number] => 20170184611 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-29 [patent_title] => 'BIOMARKER-BASED METHODS AND BIOCHIPS FOR AIDING THE DIAGNOSIS OF STROKE' [patent_app_type] => utility [patent_app_number] => 15/457297 [patent_app_country] => US [patent_app_date] => 2017-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8732 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15457297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15540899 [patent_doc_number] => 10570215 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-02-25 [patent_title] => Humanized monoclonal antibody, inhibiting the enzymatic activity of vascular endothelial lipase [patent_app_type] => utility [patent_app_number] => 15/456041 [patent_app_country] => US [patent_app_date] => 2017-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 129 [patent_no_of_words] => 18196 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15456041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15147765 [patent_doc_number] => 20190352360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-21 [patent_title] => HMGB1 MUTANTS [patent_app_type] => utility [patent_app_number] => 16/468475 [patent_app_country] => US [patent_app_date] => 2017-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10558 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16468475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13371919 [patent_doc_number] => 20180237500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-23 [patent_title] => METHOD OF PREVENTING REPERFUSION INJURY IN REPERFUSION THERAPY [patent_app_type] => utility [patent_app_number] => 15/439807 [patent_app_country] => US [patent_app_date] => 2017-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4582 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15439807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16650014 [patent_doc_number] => 10927177 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-02-23 [patent_title] => Methods of treatment using anti-c-met antibodies [patent_app_type] => utility [patent_app_number] => 16/075304 [patent_app_country] => US [patent_app_date] => 2017-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14062 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16075304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11851733 [patent_doc_number] => 20170226225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-10 [patent_title] => 'ANTI-COAGULATION FACTOR XI ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 15/409607 [patent_app_country] => US [patent_app_date] => 2017-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 34500 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15409607 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11605640 [patent_doc_number] => 20170122942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-04 [patent_title] => 'Methods of Treating Cardiovascular Diseases and Predicting the Efficacy of Exercise Therapy' [patent_app_type] => utility [patent_app_number] => 15/409283 [patent_app_country] => US [patent_app_date] => 2017-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14527 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15409283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14243907 [patent_doc_number] => 10272136 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-30 [patent_title] => Diagnostic and therapeutic uses of gelsolin in renal failure [patent_app_type] => utility [patent_app_number] => 15/407458 [patent_app_country] => US [patent_app_date] => 2017-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18408 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15407458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15281811 [patent_doc_number] => 10513561 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-24 [patent_title] => Anti-MYL9 antibody [patent_app_type] => utility [patent_app_number] => 16/063515 [patent_app_country] => US [patent_app_date] => 2017-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 43 [patent_no_of_words] => 21513 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16063515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16555773 [patent_doc_number] => 20210000921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-07 [patent_title] => METHODS AND COMPOSITIONS FOR MODULATING THYMIC FUNCTION [patent_app_type] => utility [patent_app_number] => 16/067948 [patent_app_country] => US [patent_app_date] => 2017-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42690 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16067948 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11590001 [patent_doc_number] => 20170114412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-27 [patent_title] => 'ROBO2 INHIBITORY COMPOSITIONS COMPRISING SLIT2-BINDING EXTRACELLULAR DOMAIN OF ROBO2' [patent_app_type] => utility [patent_app_number] => 15/399848 [patent_app_country] => US [patent_app_date] => 2017-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 39921 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15399848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14294457 [patent_doc_number] => 10287345 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-14 [patent_title] => Methods for inhibiting myostatin activation by administering anti-pro/latent myostatin antibodies [patent_app_type] => utility [patent_app_number] => 15/400825 [patent_app_country] => US [patent_app_date] => 2017-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 63 [patent_figures_cnt] => 114 [patent_no_of_words] => 68848 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1251 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15400825 [rel_patent_id] =>[rel_patent_doc_number] =>)